Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Glaxo Sees Up to $100 Million in Initial Costs From Brexit
Glaxo Sees Up to $100 Million in Initial Costs From Brexit
Glaxo Sees Up to $100 Million in Initial Costs From Brexit
Submitted by
admin
on March 18, 2018 - 11:42am
Source:
Bloomberg
News Tags:
GSK
Brexit
Headline:
Glaxo Sees Up to $100 Million in Initial Costs From Brexit
Do Not Allow Advertisers to Use My Personal information
